Fundraising Fox
/Companies
Sign in

Scorpion Therapeutics

Boston, US · Founded 2020 · Delaware corporation · 10 known investors

Find your way into Scorpion Therapeutics

Sign up to see every warm intro you have to Scorpion Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Scorpion Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in
Biotech

Founders & leadership

Scorpion Therapeutics was founded in 2020 by Adam Friedman and Gary Glick.

AFAdam Friedman
Adam FriedmanCo-founder · President & CEO2024–2025Chief Executive Officer at Antares Therapeutics
GGGary Glick
Gary GlickCo-founder
AFAndrew Fedder
Andrew FedderGeneral Counsel2021–2025Executive Officer, Director at Antares Therapeutics
DSDarrin Stuart
Darrin StuartChief Scientific Officer2020–2025Darrin Stuart is an oncology scientist with over 25 years of experience in cancer drug discovery and development. He previously led small molecule drug discovery projects at Novartis, including work on RAF kinase inhibitor programs, and translated preclinical research into clinical trial design and patient stratification strategies.
EJ
Erica JacksonChief Discovery OfficerShe has experience in drug discovery and development across large and small molecules, with expertise in cancer biology including tumor heterogeneity, cancer stem cells, and mechanisms of drug resistance, as well as in vivo cancer modeling.
AV
Amanda ValentinoExecutive
PJ
Peter Joseph Campisi, Jr.Executive

Board

ONOleg Nodelman
Oleg NodelmanBoard directorFounder and Portfolio Manager at EcoR1 Capital
OS
Otello StampacchiaBoard directorManaging Director at Omega Funds
SC
Shelley ChuBoard directorPromoter at Abingworth
JFJean-Francois Formela
Jean-Francois FormelaBoard directorPartner at Atlas Venture
SS
Saurabh SahaBoard director

Investors · 10

Avoro Capital Advisorslisted by Avoro Capital AdvisorsNew York

How we know: Avoro Capital Advisors's portfolio page · Not right? Tell us

EcoR1 Capitallisted by EcoR1 CapitalSan Franciscovia Oleg Nodelman · board

How we know: board seat on SEC Form D · Not right? Tell us

Frazier Life Scienceslisted by Frazier Life SciencesPalo Altovia Kevin Li · led

How we know: Frazier Life Sciences's portfolio page · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

Nextech Investlisted by Nextech InvestZurich · $648K – $3.2M

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Vida Ventureslisted by Vida VenturesLos Angeles

How we know: Vida Ventures's portfolio page · a partner's Signal profile · press coverage · the VCSheet dataset · Not right? Tell us

AbingworthreportedLondon · $15M – $30M

How we know: press coverage · Not right? Tell us

Lightspeed Venture PartnersreportedMenlo Park · $1M – $5M

How we know: funding news · Not right? Tell us

Olive Tree CapitalreportedBoston

How we know: the VCSheet dataset · Not right? Tell us

Omega FundsinferredBoston

How we know: board seat on SEC Form D · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$297.4M disclosed across 3 of 4 rounds · 2020–2025

▶$125.7MraisedJul 2024 · 38 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew FedderExecutive Officer
  • Oleg NodelmanDirector
  • Otello StampacchiaDirector
  • Adam FriedmanExecutive Officer, Director
  • Shelley ChuDirector
  • Darrin StuartExecutive Officer
  • Erica JacksonExecutive Officer
  • Jean-Francois FormelaDirector
  • Amanda ValentinoExecutive Officer
  • Jeffrey AlbersDirector
  • Saurabh SahaDirector
  • Arjun GoyalDirector
  • Keith FlahertyDirector
  • Mark ChaoExecutive Officer
  • Brian PiperExecutive Officer
Offering amount
$150M
Amount sold
$125.7M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$147MraisedDec 2020 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jean-Francois FormelaDirector
  • Arjun GoyalDirector
  • Peter Joseph Campisi, Jr.Executive Officer
  • Keith FlahertyDirector
  • Otello StampacchiaDirector
  • Shelley ChuDirector
  • Gary GlickExecutive Officer, Director
Amount sold
$147M
First sale
Nov 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$24.7MraisedMay 2020 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gary GlickExecutive Officer, Director
  • Peter Joseph Campisi, Jr.Executive Officer
Amount sold
$24.7M
First sale
Apr 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Scorpion Therapeutics went on to found or lead other companies.

Jean-François FormelaDirectorFounded Korro BioArjun GoyalDirectorFounded Affini-T TherapeuticsAdam FriedmanExecutive Officer, DirectorFounded Antares Therapeutics

Frequently asked questions

Who founded Scorpion Therapeutics?
Scorpion Therapeutics was founded by Adam Friedman, Gary Glick in 2020.
Who are Scorpion Therapeutics's investors?
Scorpion Therapeutics's investors include Atlas Venture, Avoro Capital Advisors, EcoR1 Capital, Frazier Life Sciences, Nextech Invest, Vida Ventures, Abingworth, Lightspeed Venture Partners and 2 more.
How much funding has Scorpion Therapeutics raised?
Scorpion Therapeutics has disclosed $297.4M raised across 3 of its 4 known rounds.
Where is Scorpion Therapeutics headquartered?
Scorpion Therapeutics is headquartered in Boston, US.